RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+25.3%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$474M
AUM Growth
+$94.5M
(+25%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
10.74%
Top 10 Holdings %
Top 10 Hldgs %
76.63%
Holding
34
New
6
Increased
17
Reduced
4
Closed
6
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$36.6M |
| 2 |
Arbutus Biopharma
ABUS
|
$13.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$11.4M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$7.3M |
| 5 |
Omeros
OMER
|
$4.73M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$28M |
| 2 |
Incyte
INCY
|
$11M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.14M |
| 4 |
IVTY
Invuity, Inc
IVTY
|
$3.24M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$2.98M |
Sector Composition
| 1 | Healthcare | 97.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
argenx
ARGX
$45.3B
| $530K | 0.11% |
+24,970
| New | +$530K |
|
|
IVTY
27
DELISTED
Invuity, Inc
IVTY
| $173K | 0.04% |
23,830
-446,337
| -95% | -$3.24M |
|
|
SRTSW
28
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
| $93K | 0.02% |
155,000
| – | – |
|
29
Celldex Therapeutics
CLDX
$1.54B
| – | – |
-16,113
| Closed | -$873K |
|
|
30
Incyte
INCY
$17.1B
| – | – |
-82,490
| Closed | -$11M |
|
31
Natera
NTRA
$23.1B
| – | – |
-31,693
| Closed | -$281K |
|
32
Sensus Healthcare
SRTS
$52.4M
| – | – |
-90,404
| Closed | -$397K |
|
|
TMBR
33
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| – | – |
-86
| Closed | -$648K |
|
|
MDCO
34
DELISTED
Medicines Co
MDCO
| – | – |
-572,689
| Closed | -$28M |
|